When we added an elevated serum AMH concentration as a surrogate marker for PCOM to the ovarian US conducted initially, seven out of those 25 patients with group WHO II OD now fulfilled diagnostic criteria of non-hyperandrogenic PCOS. Here, AMH is linked to polycystic ovary syndrome.